arginyl-glycyl-aspartic acid has been researched along with Chlamydia Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattarai, SR; Dean, D; Lee, SW; Yoo, SY | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and Chlamydia Infections
| Article | Year |
|---|---|
Engineered phage-based therapeutic materials inhibit Chlamydia trachomatis intracellular infection.
Topics: Bacteriophage M13; Chlamydia Infections; Chlamydia trachomatis; HeLa Cells; Humans; Oligopeptides | 2012 |